OMAPiX and Cornell Epigenomics Core Facility Announced as Inaugural Certified Partners
San Diego, CA — December 4, 2025 — Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced OMAPiX and Cornell Epigenomics Facility as the first certified partners in its new Certified Service Provider (CSP) Program, which establishes a network of validated laboratories offering Teton™ CytoProfiling workflows that simultaneously profile RNA, proteins, and phospho-proteins in individual cells at subcellular resolution on the AVITI24™ 5D Multiomic system.
Each certified provider undergoes independent validation by Element to ensure consistent performance and data quality standards for researchers seeking specialized single-cell spatial analysis services.
"Element is built on the principle that breakthrough technologies should be accessible to researchers everywhere," said Edwin Hauw, senior vice president of marketing and product management at Element Biosciences. "This program exemplifies our commitment to removing barriers between cutting-edge innovation and the scientific community through strategic partnerships with world-class laboratories."
OMAPiX, a contract research organization based in Frederick, Maryland, specializing in spatial omics and in situ profiling services
"Integrating RNA, protein, and phospho-protein profiling requires sophisticated technical expertise and validated methodologies," said Linda Orzolek, Head of Lab Operations for OMAPiX. "Element's program certifies our laboratory's technical competency in delivering consistent, high-quality data from AVITI24, and we look forward to advancing researchers' ability to understand complex cellular mechanisms through this innovative technology.”
Cornell Epigenomics Core Facility, operated by Cornell Research and Innovation
"The AVITI24 system provides unprecedented data dimensionality that transforms how we study cellular responses," said William Lai, Director of the Cornell Epigenomics Facility. "Whether examining drug effects on apoptosis or stress responses, this technology delivers a truly holistic view. As a certified provider, we're excited to bridge real-world research needs with platform innovation."
Element plans to expand the program with additional partners in 2026. Researchers can connect with certified service providers through Element's online directory at https://www.elementbiosciences.com/become-a-certified-service-provider-with-element-biosciences
About Element Biosciences, Inc.
Element Biosciences is a biology company transforming the pace and accessibility of scientific discovery. Element empowers scientists with advanced technologies that capture multiple layers of biology—from genes to proteins—delivering richer data and faster insights. Through powerful new technologies, Element is fueling research and drug discovery breakthroughs impacting diagnostic and therapeutic developments—opening the world of biology to new possibilities that improve lives everywhere. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact:
Michael Sullivan
Media@Elembio.com